July 30, 2020 / 4:17 AM / 16 days ago

Sensex, Nifty pare early gains as stalled U.S. aid talks hit global sentiment

BENGALURU (Reuters) - Indian shares erased early gains to end lower on Thursday, as a stalemate on U.S. fiscal support that investors hoped would help cushion the impact of the coronavirus outbreak dented global sentiment.

A broker reacts while trading at his computer terminal at a stock brokerage firm in Mumbai, India, August 24, 2015. REUTERS/Danish Siddiqui/Files

The NSE Nifty 50 index .NSEI slid 0.9% to close at 11,102.15 and the benchmark S&P BSE Sensex .BSESN dropped 0.88% to 37,736.07, dragged by banking and financial stocks.

MSCI’s world equity index .MIWD00000PUS edged lower as focus shifted from the U.S. Federal Reserve’s vow to support the world’s largest economy to negotiations over a new coronavirus relief package for the country.

U.S. President Donald Trump said on Wednesday that his administration and Democrats in Congress were still “far apart” on a new coronavirus relief bill.

Senate Republican leaders on Monday rolled out a $1 trillion package of proposals, which Democrats rejected as inadequate.

“If the United States lowers the relief amount, consumption could weaken dramatically,” said Rusmik Oza, head of fundamental research at Kotak Securities in Mumbai.

“Global markets are keenly watching what’s happening in the United States.”

In India, virus cases rose by over 50,000 in the last 24 hours and touched 1.58 million by Thursday morning, government data showed, with the country easing restrictions such as the night-time curfew and allowing gyms to open from next month.

Among equities, the Nifty banking index fell 1.95%, while the Nifty financials index .NIFTYFIN was down 1.8%.

Large Shadow lender HDFC (HDFC.NS) fell 3.8% despite reporting an upbeat profit in the quarter to June.

Indusind Bank (INBK.NS) dropped 4%, while Axis Bank (AXBK.NS) fell 3.2%. Refiner Bharat Petroleum Corp (BPCL.NS) was the top laggard, shedding about 7.9%.

Dr. Reddy’s Labs (REDY.NS) rose nearly 6% in the session to a record high and topped the Nifty gainers after the generic drugmaker reported a better-than-expected quarterly profit on Wednesday.

Reporting by Derek Francis in Bengaluru; Editing by Rashmi Aich

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below